KATIE CAISON: Open Payments
NPI 1578256350 · WHITEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,586 in 80 payments from 20 companies in 2025. Trend: 2023 $970 · 2024 $2,637 · 2025 $1,586
Food & beverage: $1,586
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $365 |
| ABBVIE INC. | 14 | $191 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $178 |
| Amgen Inc. | 18 | $161 |
| Astellas Pharma US Inc | 1 | $124 |
| Axsome Therapeutics, Inc. | 5 | $85 |
| PFIZER INC. | 4 | $72 |
| TOLMAR, INC. | 3 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $65 |
| Abbott Laboratories | 3 | $57 |
Products named: XIFAXAN, Wegovy, OTEZLA, Ozempic, VRAYLAR, Veozah, JATENZO, Auvelity.
Industry payments across NC — which companies pay providers there.
